The pretreatment albumin-globulin ratio can independently predict survival outcomes in patients with urothelial carcinoma, according to a recent meta-analysis. Zhongyou Xia of the Nanchong Central Hospital, The Second Clinical College, North Sichuan Medical College, and colleagues conducted the analysis and published its results in Frontiers in Oncology. ...
Urothelial Carcinoma Knowledge Hubs
Curated clinical content based on urothelial cancer types, therapies, and technologies
The first PET scans using Illuccix, Telix’s PSMA-PET imaging agent, have been carried out in cooperation with BAMF Health.
Few biomarkers predict therapeutic response to radiation or adjunctive treatments in PCa patients treated with radiotherapy.
Nanobubbles can target membrane proteins, including PSMA, to bind to receptors that are overexpressed in cancer cells.